• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弗氏柠檬酸杆菌菌株中与喹诺酮耐药性发展相关的AmpC型β-内酰胺酶产生减少。

Decreased production of AmpC-type beta-lactamases associated with the development of resistance to quinolones in Citrobacter freundii strains.

作者信息

Tavío Pérez M M, Amicosante G, Franceschini N, Vila J, Ruiz J, Oratore A, Martín-Sánchez A M, Jiménez de Anta M T

机构信息

Department of Clinical Sciences, School of Medicine, University of Las Palmas de G.C., Spain.

出版信息

Microb Drug Resist. 1999 Winter;5(4):235-40. doi: 10.1089/mdr.1999.5.235.

DOI:10.1089/mdr.1999.5.235
PMID:10647079
Abstract

The effect of fluoroquinolones in Citrobacter freundii strains that results in a decreased expression of cephalosporin-hydrolysing beta-lactamases was studied. Resistance to broad-spectrum cephalosporins and penicillins in two C. freundii clinical isolates was associated with moderate production of chromosomal AmpC-type-beta-lactamase in addition to changes in the outer membrane proteins profile with respect to wild-type C. freundii strains. Ten quinolone-resistant mutants were derived from the two clinical isolates using increasing fluoroquinolone concentrations. The level of susceptibility to cephalosporins and meropenem of these 10 mutants was increased and was associated with a 3.6-32% diminution in the hydrolyzing activity of their periplasmic extracts containing beta-lactamases on cephaloridine as compared with those from their parent strains. Susceptibility to cephalosporins and meropenem, as well as the expression of chromosomal AmpC-type-beta-lactamase in C. freundii strains, was influenced by the exposure to quinolones.

摘要

研究了氟喹诺酮类药物对弗氏柠檬酸杆菌菌株的影响,该影响导致头孢菌素水解β-内酰胺酶的表达降低。两株弗氏柠檬酸杆菌临床分离株对广谱头孢菌素和青霉素的耐药性,除了外膜蛋白谱相对于野生型弗氏柠檬酸杆菌菌株发生变化外,还与染色体AmpC型β-内酰胺酶的中度产生有关。使用逐渐增加的氟喹诺酮浓度从这两株临床分离株中获得了10个喹诺酮耐药突变体。这10个突变体对头孢菌素和美罗培南的敏感性水平有所提高,并且与它们含有β-内酰胺酶的周质提取物对头孢菌素的水解活性相比其亲本菌株降低了3.6%-32%有关。弗氏柠檬酸杆菌菌株对头孢菌素和美罗培南的敏感性以及染色体AmpC型β-内酰胺酶的表达受到喹诺酮类药物暴露的影响。

相似文献

1
Decreased production of AmpC-type beta-lactamases associated with the development of resistance to quinolones in Citrobacter freundii strains.弗氏柠檬酸杆菌菌株中与喹诺酮耐药性发展相关的AmpC型β-内酰胺酶产生减少。
Microb Drug Resist. 1999 Winter;5(4):235-40. doi: 10.1089/mdr.1999.5.235.
2
High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression.弗氏柠檬酸杆菌临床分离株中的高水平碳青霉烯耐药性是由KPC-2产生和孔蛋白表达降低共同导致的。
J Med Microbiol. 2008 Mar;57(Pt 3):332-337. doi: 10.1099/jmm.0.47576-0.
3
Ciprofloxacin, salicylate, and 2,4-dinitrophenol decrease production of AmpC-type beta-lactamase in two Citrobacter freundii clinical isolates.
Microb Drug Resist. 2005 Fall;11(3):225-31. doi: 10.1089/mdr.2005.11.225.
4
Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37.一株携带新型染色体编码AmpCβ-内酰胺酶CMY-37的耐头孢吡肟和头孢匹罗弗氏柠檬酸杆菌临床分离株的出现。
Int J Antimicrob Agents. 2008 Sep;32(3):256-61. doi: 10.1016/j.ijantimicag.2008.04.019. Epub 2008 Jul 10.
5
Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase.希腊医院分离出的大肠杆菌菌株中的可转移性C类β-内酰胺酶以及与弗氏柠檬酸杆菌AmpCβ-内酰胺酶密切相关的两种酶变体(LAT-3和LAT-4)的特性
J Antimicrob Chemother. 1998 Oct;42(4):419-25. doi: 10.1093/jac/42.4.419.
6
In vitro selected fluoroquinolone-resistant mutants of Citrobacter freundii: analysis of the quinolone resistance acquisition.体外筛选出的弗氏柠檬酸杆菌氟喹诺酮耐药突变体:喹诺酮耐药性获得情况分析
J Antimicrob Chemother. 2000 Apr;45(4):521-4. doi: 10.1093/jac/45.4.521.
7
Origin and evolution of the AmpC beta-lactamases of Citrobacter freundii.弗氏柠檬酸杆菌AmpC β-内酰胺酶的起源与进化
Antimicrob Agents Chemother. 2002 May;46(5):1190-8. doi: 10.1128/AAC.46.5.1190-1198.2002.
8
CFE-1, a novel plasmid-encoded AmpC beta-lactamase with an ampR gene originating from Citrobacter freundii.CFE-1,一种新型的质粒编码AmpCβ-内酰胺酶,其ampR基因源自弗氏柠檬酸杆菌。
Antimicrob Agents Chemother. 2004 Apr;48(4):1151-8. doi: 10.1128/AAC.48.4.1151-1158.2004.
9
Identification of CFE-2, a new plasmid-encoded AmpC β-lactamase from a clinical isolate of Citrobacter freundii.鉴定弗氏柠檬酸杆菌临床分离株中的新型质粒编码 AmpCβ-内酰胺酶 CFE-2。
Int J Antimicrob Agents. 2018 Sep;52(3):421-424. doi: 10.1016/j.ijantimicag.2018.06.013. Epub 2018 Jun 23.
10
Characterization of chromosomal qnrB and ampC alleles in Citrobacter freundii isolates from different origins.不同来源弗氏柠檬酸杆菌分离株中染色体qnrB和ampC等位基因的特征分析。
Infect Genet Evol. 2015 Oct;35:214-20. doi: 10.1016/j.meegid.2015.07.011. Epub 2015 Jul 10.